APA (7th ed.) Citation

Maschmeyer, G., Bullinger, L., Garcia-Vidal, C., Herbrecht, R., Maertens, J., Menna, P., . . . Calandra, T. (2022). Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN). Leukemia, 36(5), 1215. https://doi.org/10.1038/s41375-022-01556-7

Chicago Style (17th ed.) Citation

Maschmeyer, Georg, Lars Bullinger, Carolina Garcia-Vidal, Raoul Herbrecht, Johan Maertens, Pierantonio Menna, Livio Pagano, Anne Thiebaut-Bertrand, and Thierry Calandra. "Infectious Complications of Targeted Drugs and Biotherapies in Acute Leukemia. Clinical Practice Guidelines by the European Conference on Infections in Leukemia (ECIL), a Joint Venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)." Leukemia 36, no. 5 (2022): 1215. https://doi.org/10.1038/s41375-022-01556-7.

MLA (9th ed.) Citation

Maschmeyer, Georg, et al. "Infectious Complications of Targeted Drugs and Biotherapies in Acute Leukemia. Clinical Practice Guidelines by the European Conference on Infections in Leukemia (ECIL), a Joint Venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)." Leukemia, vol. 36, no. 5, 2022, p. 1215, https://doi.org/10.1038/s41375-022-01556-7.